Physician profile
David A Hervig
NPI 1841221678
$574.51
in general payments reported to CMS, 2019-2025
9 companies · $95.26 in 2025
The $95.26 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2023: $103 · 2024: $257 · 2025: $95.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $144.64 | 2024 | |
| Lilly USA, LLC | $104.24 | 2021 | |
| Smith+Nephew, INC. | $102.67 | 2023 | Iodosorb Ointment 40g USA, Collagenase Santyl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Abbvie INC. | $82.81 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.79 | 2024 | Xifaxan |
| Pfizer INC. | $27.26 | 2024-2025 | |
| Exact Sciences Corporation | $23.30 | 2024 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $19.43 | 2024 | Nuzyra |
| Dexcom, INC. | $14.37 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hervig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.